India  

JCVI announces new recommendation for Covid-19 jabs

Video Credit: ODN - Duration: 00:32s - Published
JCVI announces new recommendation for Covid-19 jabs

JCVI announces new recommendation for Covid-19 jabs

Covid booster jabs will be offered to those aged between 40 and 49, whilst 16 and 17-year-olds will be offered a second dose of the Pfizer vaccine.

Report by Czubalam.

Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn


You Might Like


💡 newsR Knowledge: Other News Mentions

COVID-19 COVID-19 Contagious disease caused by SARS-CoV-2

Kenneth Branagh to play Boris Johnson in new Sky drama about PM's handling of COVID pandemic - watch the trailer here

A new teaser video has been released of Sky's new drama series about Prime Minister Boris Johnson's handling of the COVID pandemic.
Sky News

Jonathan Van-Tam misses COVID knighthood ceremony after testing positive

Professor Sir Jonathan Van-Tam missed his knighthood ceremony because he caught COVID-19.
Sky News
Truss: Inflation is creating a difficult global situation [Video]

Truss: Inflation is creating a difficult global situation

Foreign Secretary Liz Truss says the world is facing a "very difficult situation" because of the "appalling global headwinds" caused by the Russian invasion of Ukraine and Covid. She warns a windfall tax is "likely to deter investment" and stresses the Chancellor Rishi Sunak is looking "very hard" at what can be done but warns that the government can't "completely cushion" people from the effects of inflation. Report by Edwardst. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 01:52Published
Covid-19 update: India logs 1,829 new cases and 33 deaths in last 24 hours | Oneindia News [Video]

Covid-19 update: India logs 1,829 new cases and 33 deaths in last 24 hours | Oneindia News

According to the Union Health ministry's data, India added 1,829 Covid cases and 33 Covid-related deaths in the last 24 hours. #CovidIndia #Covid19 #CovidCases #CoronaDeaths India, XE variant, Omicron, New Covid cases, Active cases, Daily new cases, Covid fatalities, Delta plus variant, Corona second wave, Corona third wave, Corona recovery rate, Weekly positivity rate, Covid tests done, Coronavirus case count, India, Covid vaccination drive, Omicron alert, Covid guidelines.

Credit: Oneindia    Duration: 01:06Published

Scientists develop tool to identify patients most at risk of COVID death

An algorithm to identify people most at risk of dying from COVID when being treated in a hospital has been developed by scientists.
Sky News

Joint Committee on Vaccination and Immunisation UK government advisory group

Covid boosters offered to elderly and vulnerable in spring [Video]

Covid boosters offered to elderly and vulnerable in spring

Covid booster jabs will be offered this spring to the most vulnerable people in the country following new advice from the Joint Committee on Vaccination and Immunisation (JCVI). Dr Nikita Kanani, deputy lead for NHS England's vaccination programme, said GPs would begin getting in touch with those eligible which includes people aged 75 and over and those who are immunosuppressed. Report by Alibhaiz. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 00:45Published

Pfizer Pfizer American multinational pharmaceutical corporation

Pfizer’s COVID Booster Shot for 5 to 11 Year Olds Authorized by FDA [Video]

Pfizer’s COVID Booster Shot for 5 to 11 Year Olds Authorized by FDA

Pfizer’s COVID Booster Shot , for 5 to 11 Year Olds, Authorized by FDA. NBC News reports on May 17, the Food and Drug Administration (FDA)... … announced it had authorized Pfizer-BioNTech's coronavirus booster dose for 5 to 11 year olds. The FDA says eligible recipients of a booster dose could receive the extra shot starting five months after their initial two-dose series. Per NBC News, Pfizer's booster shot for 5 to 11 year olds is 10 micrograms ... . ... a third of the dosage given to citizens 12 and older. Following the FDA's ruling, it is now up to the Centers for Disease Control and Prevention (CDC) to recommend how to implement boosters for the age group. CDC data shows less than one third of 5 to 11 year olds in the United States have recieved the primary series of a COVID-19 vaccine. Experts say booster shots offer better protection against the omicron strain and its associated subvariants. The CDC's Advisory Committee on Immunization Practices will reportedly discuss booster shots on May 19. Dr. Rochelle Walensky, the Director of the CDC, should have her final recommendation following the committee's discussion

Credit: Wibbitz Top Stories    Duration: 01:30Published
Pfizer's First Quarter Profits Blast Past 2022 Forecast [Video]

Pfizer's First Quarter Profits Blast Past 2022 Forecast

Pfizer's First Quarter , Profits Blast Past, 2022 Forecast. ABC reports that Pfizer's COVID-19 vaccine and treatment sales helped propel the pharmaceuticals company beyond Wall Street's first quarter expectations. . Pfizer's coronavirus vaccine Comirnaty raked in over $13 billion in sales for the first quarter. . Pfizer's coronavirus vaccine Comirnaty raked in over $13 billion in sales for the first quarter. . The vaccine has remained Pfizer's top selling product for almost the last year. . The drugmaker's pill treatment Paxloid reportedly added an additional $1.5 billion to the company's sales. . ABC reports that Pfizer's, profits grew 61% , in the first quarter. . On May 3, the company posted a net income of $7.86 billion and first quarter adjusted earnings of $1.62 per share. . The results easily exceeded the $1.49 increase predicted by industry analysts. . Compared to the same time last year, the company's revenue skyrocketed 77% , to reach $25.66 billion. . According to ABC, the drugmaker expects the company's total revenue in 2022 to reach between $98 billion and $102 billion. . Pfizer's COVID vaccine launched late in 2020 and quickly became the company's top selling product by the second quarter of 2021. In December of 2021, Pfizer's stock reached an all-time high of $61.71 per share.

Credit: Wibbitz Top Stories    Duration: 01:31Published
Biden Administration Secures 20 Million Courses of Paxlovid [Video]

Biden Administration Secures 20 Million Courses of Paxlovid

Biden Administration Secures , 20 Million Courses of Paxlovid. Biden Administration Secures , 20 Million Courses of Paxlovid. CNN reports that on April 25, a senior administration official said , 20 million treatment courses of Pfizer's antiviral COVID pill have been secured for the United States to purchase. 100,000 treatment courses will be provided to pharmacies per quarter as need and uptake are observed. . A treatment course of Paxlovid consists of taking three pills twice a day for five days. CNN reports that Pfizer released data last year showing that its antiviral COVID pill reduced the risk of hospitalization or death by 89% if taken within a few day of exhibiting symptoms. Paxlovid first became authorized by the FDA at the end of December. And there were very, very few pills around. The administration worked incredibly hard to both increase production and acquisition, and the good news is we’ve made really substantial progress, Dr. Ashish Jha, White House COVID-19 Response Coordinator, to NPR. Now we’ve got to turn those pills into prescriptions and into the things that patients can get so that they can get better if they get infected. We have a big set of efforts that we have been working on and launching, and we’re going to be doing a lot more this week, Dr. Ashish Jha, White House COVID-19 Response Coordinator, to NPR. On April 26, the administration is expected to announce expanded access to the pills via its federal antiviral pharmacy program. It is estimated that over 30,000 locations may provide free treatments in the future through the test-to-treat initiative. While the purchase of a significant amount of treatment courses has been secured thus far. CNN reports that the administration "will not be able to purchase more" unless it secures further funding from Congress

Credit: Wibbitz Top Stories    Duration: 01:30Published
Moderna Working on Vaccine Booster That Targets the Omicron Variant [Video]

Moderna Working on Vaccine Booster That Targets the Omicron Variant

Moderna Working on , Vaccine Booster That Targets, the Omicron Variant. The Associated Press reports that Moderna is developing an updated COVID-19 booster that offers protection against the omicron variant. On April 19, the pharmaceutical company released data suggesting that work on the updated booster was making progress. Prior to the emergence of omicron, Moderna had been developing a booster with added protection against the beta variant of coronavirus. According to the company, people who received that specific booster produced more antibodies capable of fighting a number of variants. AP reports that the omicron variant is able to more easily slip past the immune system's defenses than the original coronavirus. According to health officials, distributing boosters every few months does not present a practical solution to the mutating virus. As a result, Moderna and its rival Pfizer are testing "bivalent" shots which mixes each company's original vaccine with an updated omicron version. . As a result, Moderna and its rival Pfizer are testing "bivalent" shots which mixes each company's original vaccine with an updated omicron version. . Moderna's bivalent shot reportedly includes 32 variant mutations of the coronavirus. Studies on the new bivalent shots are currently underway in the United States and Britain. . Results from the studies are expected by late June

Credit: Wibbitz Top Stories    Duration: 01:30Published
Booster Shots in Children Ages 5–11 Increase Omicron Antibodies, Pfizer Says [Video]

Booster Shots in Children Ages 5–11 Increase Omicron Antibodies, Pfizer Says

Booster Shots in Children Ages 5–11 , Increase Omicron Antibodies, Pfizer Says. NBC News reports a booster shot of the Pfizer-BioNTech coronavirus vaccine increases antibody protection in children ages 5-11, the company said on April 14. NBC News reports a booster shot of the Pfizer-BioNTech coronavirus vaccine increases antibody protection in children ages 5-11, the company said on April 14. Given half a year after the initial series of two doses, a booster shot of the Pfizer-BioNTech vaccine increased antibody levels sixfold. In Pfizer's clinical trial, 140 children ages 5 through 11 received a booster shot. According to NBC News, data has not yet been made available to independent researchers for review. In the era of Omicron, booster doses of COVID vaccines have been hit and miss. In adults, a booster dose of Pfizer's vaccine wanes dramatically after four months. Health experts say the same trends are likely to occur in children. For adults, Pfizer's vaccine is 30 micrograms per dose. For children, vaccines are 10 micrograms per dose. Earlier this year, New York Department of Health researchers found Pfizer's vaccine to offer minimal protection against infection in children. But according to NBC, the CDC later said two doses in children offered ample protection against severe infections. But according to NBC, the CDC later said two doses in children offered ample protection against severe infections

Credit: Wibbitz Top Stories    Duration: 01:30Published

Facebook Facebook Social media service

PM offers Rangers 'best wishes' for the Europa League final [Video]

PM offers Rangers 'best wishes' for the Europa League final

Prime Minister Boris Johnson offers his "best wishes" to Rangers as they take on Eintracht Frankfurt in the Europa League Final. Rangers, who finished second to their fierce rivals Celtic in the Scottish Premiership, shocked Frankfurt's compatriots RB Leipzig in the semi-final. Report by Edwardst. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 00:10Published
Starmer: Govt windfall tax U-turn inevitable, get on with it [Video]

Starmer: Govt windfall tax U-turn inevitable, get on with it

Labour Leader Sir Keir Starmer says a government U-turn on a windfall tax on energy companies is "inevitable" and the fact that Prime Minister Boris Johnson continues to "dither" shows that he does not "get" how serious the current cost of living crisis is for most people. He claims the PM is "choosing" to let people struggle when he does not need to. Report by Edwardst. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 00:49Published
Boris Johnson departs for PMQs with MP rape arrest on agenda [Video]

Boris Johnson departs for PMQs with MP rape arrest on agenda

Prime Minister Boris Johnson leaves Downing Street amidst the news that an MP from his party has been arrested on suspicion of rape. There are over 50 MPs currently under investigation from Parliament's Independent Complaints and Grievances Committee for sexual misconduct. Report by Edwardst. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 00:37Published
Labour: Rape arrest shows MP vetting process has big issues [Video]

Labour: Rape arrest shows MP vetting process has big issues

Shadow Chancellor Rachel Reeves says the arrest of an MP on suspicion of rape needs to be a "wake-up call" and shows there "clearly is an issue" with the vetting process for choosing members of parliament. She highlights the example of former Wakefield MP Imran Ahmad Khan who the Conservatives chose despite being "warned about allegations against him". Report by Edwardst. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 01:44Published
Truss: Do not blame Parliament for MP arrested for rape [Video]

Truss: Do not blame Parliament for MP arrested for rape

Foreign Secretary Liz Truss cautions against blaming "parliamentary culture" for the crimes of an individual, despite conceding there is an "issue" with the culture in Parliament after an MP was arrested on suspicion of rape. She calls for "further professionalisation" but does not think the further work that needs to be done on that front "excuses" someone from committing a criminal offence. Report by Edwardst. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 00:48Published